https://medicaldialogues.in/bioatla-enters-into-strategic-license-and-option-agreement-with-pfizer-for-a-new-class-of-antibody-therapeutics
BioAtla Enters Into Strategic License And Option Agreement With Pfizer For A New Class Of Antibody Therapeutics